Combined endovascular brachytherapy sorafenib and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus

摘要

AIMTo evaluate the safety and efficacy of combined endovascular brachytherapy (EVBT), transarterial chemoembolization (TACE), and sorafenib to treat hepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus (MPVTT).